A case of Mikulicz's disease complicated with interstitial nephritis successfully treated by high-dose corticosteroid
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-06-01
著者
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
Kuriyama K
Blood Immunology Laboratory School Of Health Sciences Faculty Of Medicine And University Hospital Un
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
HIROSE Yuko
Department of Chemistry, Faculty of Education and Human Sciences, University of Yamanashi
-
MASAKI Yasufumi
Department of Internal Medicine, Kanazawa Medical University
-
KAWABATA Hiroshi
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
SAWAKI Toshioki
Department of Hematology and Immunology, Kanazawa Medical University
-
FUKUSHIMA Toshihiro
Department of Hematology and Immunology, Kanazawa Medical University
-
UMEHARA Hisanori
Department of Hematology and Immunology, Kanazawa Medical University
-
UMEHARA Hisanori
Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University
-
Hirose Y
Department Of Hematology And Immunology Kanazawa Medical University
-
OGAWA Noriyoshi
Department of Hematology and Immunology, Kanazawa Medical University
-
Koga Hikari
Department Of Hematology And Oncology Graduate School Of Medicine Kyoto University
-
Fukushima Takuya
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Hirose Yuko
Department Of Chemistry Faculty Of Education Yamanashi University
-
Masaki Y
Department Of Hematology And Immunology Kanazawa Medical University
-
Kawabata Hiroshi
Department Of Hematology And Oncology Graduate School Of Medicine Kyoto University
-
Kawabata Hiroshi
Life Science Laboratory Mitsubishi Chemical Group Science And Technology Research Center Inc.
-
Wano Y
Department Of Hematology And Immunology Kanazawa Medical University
-
Karasawa H
Kanazawa Medical Univ. Ishikawa Jpn
-
SHIMOYAMA Kumiko
Department of Hematology and Immunology, Kanazawa Medical University
-
KARASAWA Hiromi
Department of Hematology and Immunology, Kanazawa Medical University
-
WANO Yuji
Department of Hematology and Immunology, Kanazawa Medical University
-
Sasaki K
Department Of Hematology And Immunology Kanazawa Medical University
-
Ogawa N
Department Of Hematology And Immunology Kanazawa Medical University
-
Takeshita S
Department Of Hematology And Immunology Kanazawa Medical University
-
Hirose Yuko
Department Of Bioresource Engineering Yamagata University
-
Wano Yuji
Department Of Hematology And Immunology Kanazawa Medical University
-
Masaki Yasufumi
Department Of Hematology Kinki University School Of Medicine
-
Umehara Hisanori
Department Of Hematology And Immunology Kanazawa Medical University
-
Shimoyama Kumiko
Department Of Hematology And Immunology Kanazawa Medical University
-
Fukushima Toshihiro
Department Of Hematology And Immunology Kanazawa Medical University
-
Masaki Yasufumi
Department Of Hematology And Immunology Kanazawa Medical University
-
Fukushima Takuya
Department Of Hematology Nagasaki University Hospital
-
Umehara Hisanori
Division Of Hematology And Immunology Department Of Internal Medicine Kanazawa Medical University
-
Kawabata Hiroshi
Department of Electronic Science and Engineering, Kyoto University, Kyoto 606-8501, Japan
-
UMEHARA Hisanori
Department Hematology/Immunology Kanazawa Medical University
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
- PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
- SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
- 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
- マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
- SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
- SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
- 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
- PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- A-3 インベーダ法によるSNP遺伝子型データの2変量正規混合分布に基づく分類(企画セッション:SNPデータの解析における統計的諸問題)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
- 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
- 癌と骨転移のゲノム学 (特集 骨・破壊と再生のゲノム医学)
- 遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
- SNPsと有害事象情報 (特集 分子・細胞標的治療--基礎と臨床) -- (基礎)
- がんの遺伝解析 (特集 ポストゲノム時代の医療) -- (ゲノム解析からの病態解明)
- 大腸癌表層部と先進部の発現プロファイル解析
- IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
- SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
- O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
- DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Risk of Etoposide-Related Acute Myeloid Leukemia in the Treatment of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Outpatient clinic for genetic counseling and gene testing of retinoblastoma
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Case-control study of leukemia and diagnostic radiation exposure
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- HNPCC患者の放射線治療の安全性に関する検討(第105回日本外科学会定期学術集会)
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
- Identifying haplotype block structure using an ancestor-derived model
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological Diagnoses of the Japan Adult Leukemia Study Group Acute Myeloid Leukemia Protocols: Central Review
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
- Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen
- Fractalkine in rheumatoid arthritis and allied conditions
- Primary Cutaneous Diffuse Large B Cell Lymphoma : A Clinically Aggressive Case
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Recovery of Hematopoietic Progenitor Cells in Patients With Severe Aplastic Anemia Who Obtained Good Clinical Response With a Combination Therapy of Immunosuppressive Agents and Recombinant Human Granulocyte Colony-Stimulating Factor
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Prognostic Value of Early Response to Treatment Combined with Conventional Risk Factors in Pediatric Acute Lymphoblastic Leukemia
- Risk Factors for Cytomegalovirus Retinitis Following Bone Marrow Transplantation From Unrelated Donors in Patients With Severe Aplastic Anemia or Myelodysplasia
- Sudden death of a 21-year-old female with Williams syndrome showing rare complications
- Intravascular large B cell lymphoma : proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition
- Hemophagocytosis by leukemic blasts in a case a of acute megakaryoblastic leukemia with t(16 ; 21) (p11 ; q22)
- A case of Mikulicz's disease complicated with interstitial nephritis successfully treated by high-dose corticosteroid
- Incidence of Diffuse Large B-Cell Lymphoma of Germinal Center B-Cell Origin in Whole Diffuse Large B-Cell Lymphoma : Tissue Fluorescence In Situ Hybridization Using t(14 ; 18) Compared with Immunohistochemistry
- Epstein-Barr Virus-Associated Composite Lymphoma Composed of Peripheral T-Cell Lymphoma and an Anaplastic Variant of a Diffuse Large B-Cell Type of Non-Hodgkin's Lymphoma and Strongly Expressing p53 Protein
- Epstein-Barr Virus-Associated Anaplastic Large Cell Variant of Diffuse Large B-Cell-Type Non-Hodgkin's Lymphoma with Concurrent p53 Protein Expression
- High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience